Stocks and Investing
Stocks and Investing
Fri, February 23, 2024
[ Fri, Feb 23rd 2024
] - WOPRAI
[ Fri, Feb 23rd 2024
] - WOPRAI
[ Fri, Feb 23rd 2024
] - WOPRAI
[ Fri, Feb 23rd 2024
] - WOPRAI
[ Fri, Feb 23rd 2024
] - WOPRAI
[ Fri, Feb 23rd 2024
] - WOPRAI
[ Fri, Feb 23rd 2024
] - WOPRAI
[ Fri, Feb 23rd 2024
] - WOPRAI
[ Fri, Feb 23rd 2024
] - WOPRAI
[ Fri, Feb 23rd 2024
] - WOPRAI
[ Fri, Feb 23rd 2024
] - WOPRAI
[ Fri, Feb 23rd 2024
] - WOPRAI
[ Fri, Feb 23rd 2024
] - WOPRAI
[ Fri, Feb 23rd 2024
] - WOPRAI
[ Fri, Feb 23rd 2024
] - WOPRAI
[ Fri, Feb 23rd 2024
] - WOPRAI
[ Fri, Feb 23rd 2024
] - WOPRAI
[ Fri, Feb 23rd 2024
] - WOPRAI
[ Fri, Feb 23rd 2024
] - WOPRAI
[ Fri, Feb 23rd 2024
] - WOPRAI
[ Fri, Feb 23rd 2024
] - WOPRAI
[ Fri, Feb 23rd 2024
] - WOPRAI
[ Fri, Feb 23rd 2024
] - WOPRAI
[ Fri, Feb 23rd 2024
] - WOPRAI
[ Fri, Feb 23rd 2024
] - WOPRAI
[ Fri, Feb 23rd 2024
] - WOPRAI
[ Fri, Feb 23rd 2024
] - WOPRAI
[ Fri, Feb 23rd 2024
] - WOPRAI
[ Fri, Feb 23rd 2024
] - WOPRAI
[ Fri, Feb 23rd 2024
] - WOPRAI
Tessa Romero Maintained (AGIO) at Hold with Decreased Target to $30 on, Feb 23rd, 2024
Tessa Romero of JP Morgan, Maintained "Agios Pharmaceuticals, Inc." (AGIO) at Hold with Decreased Target from $31 to $30 on, Feb 23rd, 2024.
Tessa has made no other calls on AGIO in the last 4 months.
There are 2 other peers that have a rating on AGIO. Out of the 2 peers that are also analyzing AGIO, 1 agrees with Tessa's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Salveen Richter of "Goldman Sachs" Maintained at Hold with Decreased Target to $28 on, Friday, November 3rd, 2023
This is the rating of the analyst that currently disagrees with Tessa
- Gregory Renza of "RBC Capital" Maintained at Buy with Decreased Target to $42 on, Friday, February 16th, 2024
Contributing Sources